Prevalence and clinicopathologic features of CD30-positive de novo diffuse large B-cell lymphoma in Chinese patients: a retrospective study of 232 cases.
Gong, Qi-Xing
Prevalence and clinicopathologic features of CD30-positive de novo diffuse large B-cell lymphoma in Chinese patients: a retrospective study of 232 cases. [electronic resource] - International journal of clinical and experimental pathology 2015 - 15825-35 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1936-2625
Adult
Aged
Antibodies, Monoclonal, Murine-Derived--therapeutic use
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Asian People
Biomarkers, Tumor--analysis
CD5 Antigens--analysis
China
Cyclophosphamide--therapeutic use
Disease-Free Survival
Doxorubicin--therapeutic use
Female
Humans
Immunohistochemistry
Kaplan-Meier Estimate
Ki-1 Antigen--analysis
Lymphoma, Large B-Cell, Diffuse--chemistry
Male
Middle Aged
Predictive Value of Tests
Prednisone--therapeutic use
Prevalence
Proto-Oncogene Proteins c-bcl-2
Proto-Oncogene Proteins c-myc
Retrospective Studies
Risk Factors
Rituximab
Time Factors
Treatment Outcome
Vincristine--therapeutic use
Young Adult
Prevalence and clinicopathologic features of CD30-positive de novo diffuse large B-cell lymphoma in Chinese patients: a retrospective study of 232 cases. [electronic resource] - International journal of clinical and experimental pathology 2015 - 15825-35 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1936-2625
Adult
Aged
Antibodies, Monoclonal, Murine-Derived--therapeutic use
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Asian People
Biomarkers, Tumor--analysis
CD5 Antigens--analysis
China
Cyclophosphamide--therapeutic use
Disease-Free Survival
Doxorubicin--therapeutic use
Female
Humans
Immunohistochemistry
Kaplan-Meier Estimate
Ki-1 Antigen--analysis
Lymphoma, Large B-Cell, Diffuse--chemistry
Male
Middle Aged
Predictive Value of Tests
Prednisone--therapeutic use
Prevalence
Proto-Oncogene Proteins c-bcl-2
Proto-Oncogene Proteins c-myc
Retrospective Studies
Risk Factors
Rituximab
Time Factors
Treatment Outcome
Vincristine--therapeutic use
Young Adult